Growth Metrics

Caribou Biosciences (CRBU) Non-Current Deferred Tax Liability (2020 - 2025)

Historic Non-Current Deferred Tax Liability for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to $548000.0.

  • Caribou Biosciences' Non-Current Deferred Tax Liability fell 161.58% to $548000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $548000.0, marking a year-over-year decrease of 161.58%. This contributed to the annual value of $548000.0 for FY2024, which is 9411.76% down from last year.
  • Latest data reveals that Caribou Biosciences reported Non-Current Deferred Tax Liability of $548000.0 as of Q3 2025, which was down 161.58% from $548000.0 recorded in Q2 2025.
  • Caribou Biosciences' 5-year Non-Current Deferred Tax Liability high stood at $10.9 million for Q4 2022, and its period low was $155000.0 during Q2 2021.
  • For the 5-year period, Caribou Biosciences' Non-Current Deferred Tax Liability averaged around $1.7 million, with its median value being $548000.0 (2024).
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first skyrocketed by 204387.1% in 2021, then plummeted by 9411.76% in 2024.
  • Caribou Biosciences' Non-Current Deferred Tax Liability (Quarter) stood at $3.3 million in 2021, then surged by 227.54% to $10.9 million in 2022, then decreased by 14.41% to $9.3 million in 2023, then tumbled by 94.12% to $548000.0 in 2024, then changed by 0.0% to $548000.0 in 2025.
  • Its Non-Current Deferred Tax Liability was $548000.0 in Q3 2025, compared to $548000.0 in Q2 2025 and $548000.0 in Q1 2025.